Table 7.
Baseline EuroQol-5D utility scores and VAS scores for patients with CLI
| Publication | Instrument | Baseline score | CLI population | Procedures |
|---|---|---|---|---|
| EuroQol-5D | ||||
| Egberg (2010)52 | EQ-5D | 0.54 | 15% | Percutaneous transluminal angioplasty |
| Forbes (2010)41 | EQ-5D EQ-5D SF-6D SF-6D |
0.26 0.28 0.53 0.54 |
100%a 100%a 100%a 100%a |
Angioplasty Bypass surgery Angioplasty Bypass surgery |
| Pisa (2012)35 | EQ-5D | 0.56 | 100% | NA |
| van Hattum (2011)47 | EQ-5D | 0.68 | 28% | Bypass surgery |
| Szende (2014)54 | EQ-5D | 0.825 | – | US population norm |
| VAS | ||||
| Bague (2017)50 | VAS for EQ-5D | 65.8 | 13% | Endovascular |
| Brother (2015)51 | VAS | 45.6 | 100% | Open surgery or endovascular treatment |
| Forbes (2010)41 | VAS for EQ-5D VAS for EQ-5D |
53 55 |
100%a 100%a |
Angioplasty Bypass surgery |
| Klepanec (2012)53 | VAS for EQ-5D | 51 | 100% | Intramuscular delivery of autologous bone marrow cells |
| Pisa (2012)35 | VAS for EQ-5D | 56 | 100% | NA |
| van Hattum (2011)47 | VAS for EQ-5D | 66 | 28% | Bypass surgery |
| Szende (2014)54 | VAS for EQ-5D | 80 | – | US population norm |
Note: aCLI population defined as “severe lower limb ischemia” for Forbes 201041 (BASIL trial).
Abbreviations: CLI, critical limb ischemia; EQ-5D, EuroQol-5 Dimension; NA, not applicable; SF-6D, Short-Form Six-Dimension; VAS, visual analog scale.